BioSyntech IncOver The Counter Market:BSYI
- LAST PRICE0.0000
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close--- / 0.0000
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
BioSyntech Inc | 1.2K | 0.0x | --- |
Nanobac Pharmaceuticals Inc | 250.0 | 0.0x | --- |
MetaStat Inc | 590.0 | 0.0x | --- |
Bioasis Technologies Inc | 7.9K | 0.0x | --- |
Stromacel Inc | 10.0 | 0.0x | --- |
Regnum Corp | 20.0 | 0.0x | --- |
Company Information
BioSyntech, Inc. is a Canada-based biotechnology company. The Company is developing biotherapeutic thermogels for regenerative medicine (tissue repair) and therapeutic delivery. The Company's platform technology is a family of hydrogels called BST-Gel, some of which are liquid at low temperature and solid at human body temperature. These gels can be injected or applied to a specific local site and offers properties for the local repair of damaged tissue such as cartilage, bone and chronic wounds and provide the benefit of avoiding invasive surgery. The Company's lead, late-stage product, BST-CarGel is undergoing an international pivotal trial.
Contact Information
- Headquarters
- 475 Armand-Frappier Blvd.LAVAL, QC, Canada H7V 4B3
- Phone
- ---
- Fax
- ---
Executives
- Chief Executive Officer
- Jeanne Bertonis
- Chief Financial Officer
- Catherine Auld
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.2K |
|---|---|
Revenue (TTM) | $144.6K |
Shares Outstanding | 116.4M |
BioSyntech Inc does not pay a dividend. | |
Beta | --- |
EPS | $-0.09 |
Book Value | $-0.05 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | 0.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -6,302.46% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
